𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancer

✍ Scribed by Evgeny N. Imyanitov; Oleg I. Chernitsa; Irina F. Nikiforova

Publisher
John Wiley and Sons
Year
1993
Tongue
French
Weight
703 KB
Volume
53
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Sixty DNA samples from breast carcinoma (BC) patients were analyzed by Southern blot to examine certain oncogene and anti‐oncogene alterations. Amplification of the HER‐2 oncogene was detected in 15 tumours (25%), c‐myc in 2 (3%) only and HER‐1 in none. Distribution of Hras‐1 oncogene alleles in BC did not significantly differ from that seen in healthy donors. Not a single case of RB‐1 anti‐oncogene alteration and only one of p53 suppressor gene abnormality was found when appropriate cDNA copies were used as probes. With the use of DNA polymorphic markers, loss of heterozygosity (LOH) was revealed at chromosome 17p (probe YNZ‐22) in 18 of 39 (46%) informative cases, at 17q (probe THH‐59) in 10 of 34 (29%) and at 11p (probe Hras‐1) in 8 of 30 (27%). The only significant correlation between these genetic alterations and the clinical characteristics of the tumours studied was the association of LOH at 17p with node‐negative BC (p < 0.02). Also, the tendency for correlation (p < 0.2) between HER‐2 amplification and loss of 17p sequences was revealed: 7 of 10 amplification‐positive, but only 11 of 29 amplification‐negative BC possessed o LOH of YNZ‐22 IOCUS.

📜 SIMILAR VOLUMES

Loss of heterozygosity from the short ar
Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer
✍ M. Lisa Yaremko; Chris Kutza; Judy Lyzak; Rosemarie Mick; Wendy M. Recant; Carol 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 603 KB

Loss of heterozygosity (LOH) from the short arm of chromosome 8 (8p) is frequent in many human cancers, including breast, colon, prostate. and bladder cancers. LOH occurs in two regions of 8p, 8p2I and 8p22, and suggests the presence of two separate tumor suppressor genes. In breaa cancers, 8p LOH O

Loss of heterozygosity on chromosome 9 i
Loss of heterozygosity on chromosome 9 in human breast cancer: Association with clinical variables and genetic changes at other chromosome regions
✍ Gudny Eiriksdottir; Asgeir Sigurdsson; Jon Gunnlaugur Jonasson; Bjarni A. Agnars 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 801 KB

Primary breast tumors were tested for loss of heterozygosity (LOH), on chromosome 9p with microsatellite markers restricted to a 28 cM region including the MTSl gene. LOH was found with at least I marker in 38% of the 20 I cases analyzed. A high frequency of deletions was detected at the 9p23-pZI re

High cell kinetics is associated with am
High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers
✍ Alma Contegiacomo; Claudia Pizzi; Laura De Marchis; Maurizio Alimandi; Paolo Del 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 773 KB

Cell kinetics, is a predictive parameter of breast-cancer aggressiveness, and mutations occurring in mammary tumorigenesis may favor iuncontrolled cell proliferation. In this study, cell kinetics, clinico-pathological characteristics and genetic alterations at the irrt-2, bcl-I, c-myc, c-erbB-2, and